USANA HEALTH SCIENCES INC
For the period ended Jan 3, 2026. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Mar 16, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| USANA Health Sciences, Inc. | |
| By: | /s/ Kevin G. Guest |
| Kevin G. GuestChief Executive Officer and Chairman of the Board |
Date: March 16, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date |
|---|---|---|
| /s/ Kevin G. Guest | Chief Executive Officer and Chairman of the Board | March 16, 2026 |
| Kevin G. Guest | (Principal Executive Officer) | |
| /s/ G. Douglas Hekking | Chief Financial Officer | March 16, 2026 |
| G. Douglas Hekking | (Principal Financial and Accounting Officer) | |
| /s/ Gilbert A. Fuller | Director | March 16, 2026 |
| Gilbert A. Fuller | ||
| /s/ John T. Fleming | Director | March 16, 2026 |
| John T. Fleming | ||
| /s/ J. Scott Nixon | Director | March 16, 2026 |
| J. Scott Nixon | ||
| /s/ Frederic J. Winssinger | Director | March 16, 2026 |
| Frederic J. Winssinger | ||
| /s/ Xia Ding | Director | March 16, 2026 |
| Xia Ding | ||
| /s/ Timothy E. Wood | Director | March 16, 2026 |
| Timothy E. Wood | ||
| /s/ Peggie Pelosi | Director | March 16, 2026 |
| Peggie Pelosi | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.